| Data set | Procedure | What's in this data set | Panel | Sex | Age (weeks) | Year |
|---|---|---|---|---|---|---|
|
|
body weight
with fluoxetine |
Bi-weekly. | inbred (6) | m | 4-13 wks | 2023 |
|
|
grip strength
with fluoxetine |
Forepaws and all paws. | inbred (6) | m | 4-13 wks | 2023 |
|
|
open field test
with fluoxetine |
Distance traveled, number of episodes and time in zones, stereotypy. | inbred (6) | m | 4-13 wks | 2023 |
|
|
tail suspension test
with fluoxetine |
Highly mobile, mobile, and immobile: time and percentage of time. | inbred (6) | m | 4-13 wks | 2023 |
|
|
drug and metabolite quantification
with fluoxetine |
Fluoxetine and norfluoxetine concentration (serum) after fluoxetine. | inbred (30) | m | 9-11wks | 2011 |
|
|
open field test
with fluoxetine |
Locomotor activity, exploratory and anxiety-related behavior. Fluoxetine-treated vs. control. 7 min test. | inbred (30) | m | 9-11wks | 2011 |
|
|
tail suspension test
with fluoxetine |
Immobility. Fluoxetine-treated vs. control. 5 min test. | inbred (30) | m | 9-11wks | 2011 |
|
|
biomarker quantification
with fluoxetine |
Brain tissue survey of 30 biochemical analytes. Fluoxetine-treated vs. control. 21d. | inbred (30) | m | 10-11wks | 2011 |